China's mRNA vaccine technology firm Abogen raises over $700 mln

China's Suzhou Abogen Biosciences said on Thursday it has raised over $700 million to support clinical development of its potential COVID-19 vaccine and expand pipeline of other vaccine and treatment candidates.